MENU
+Compare
FOLD
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$9.19
Change
+$0.12 (+1.32%)
Capitalization
2.76B

FOLD Amicus Therapeutics Forecast, Technical & Fundamental Analysis

a developer of orally active drugs to treat human genetic diseases

Industry Biotechnology
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for FOLD with price predictions
Feb 21, 2025

FOLD sees MACD Histogram just turned negative

FOLD saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on February 20, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on FOLD as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

FOLD moved below its 50-day moving average on February 19, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for FOLD crossed bearishly below the 50-day moving average on February 21, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FOLD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FOLD's RSI Oscillator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FOLD advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .

FOLD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 190 cases where FOLD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.205) is normal, around the industry mean (12.496). P/E Ratio (0.000) is within average values for comparable stocks, (84.451). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). FOLD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (5.294) is also within normal values, averaging (251.218).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. FOLD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FOLD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

FOLD is expected to report earnings to fall 112.67% to -1 cents per share on May 07

Amicus Therapeutics FOLD Stock Earnings Reports
Q1'25
Est.
$-0.01
Q4'24
Beat
by $0.08
Q3'24
Beat
by $0.10
Q2'24
Est.
$-0.05
Q1'24
Beat
by $0.04
The last earnings report on February 19 showed earnings per share of 9 cents, beating the estimate of 0 cents. With 2.60M shares outstanding, the current market capitalization sits at 2.76B.
A.I. Advisor
published General Information

General Information

a developer of orally active drugs to treat human genetic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
47 Hulfish Street
Phone
+1 609 662-2000
Employees
517
Web
https://www.amicusrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMGYX28.280.18
+0.64%
Allspring Emerging Markets Equity Adm
RINTX44.16-0.16
-0.36%
Russell Inv International Devd Mkts S
FMACX44.01-0.95
-2.11%
American Funds AMCAP F3
KMVAX32.70-0.88
-2.62%
Kirr Marbach Partners Value
TGWTX13.99-0.45
-3.12%
Transamerica Large Growth I3

FOLD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
+1.32%
VCYT - FOLD
43%
Loosely correlated
-4.56%
ALDX - FOLD
42%
Loosely correlated
-0.45%
SRPT - FOLD
42%
Loosely correlated
-1.96%
DNLI - FOLD
39%
Loosely correlated
-3.98%
AXON - FOLD
39%
Loosely correlated
-5.28%
More